Jo Lyn is a pharmacovigilance physician who joined P95 in March 2022. She is an anaesthetist by training and has previously worked in the UK National Health Service. She has also worked at the UK regulator, the MHRA for 8 years, within post-marketing drug safety in the team responsible for vaccines and infectious diseases therapies. At the MHRA she led mainly on the safety of HIV therapeutic agents and pre-exposure prophylaxis and has experience more recently with COVID-19 therapies and vaccines. She joins P95 from AbbVie where she was Medical Advisor to the QPPV Office.

She also has a MSc in Public Health from LSHTM. Jo Lyn is based in St Albans in the UK.